Your browser doesn't support javascript.
loading
Evaluation of a Janus kinase 1 inhibitor, PF-04965842, in healthy subjects: A phase 1, randomized, placebo-controlled, dose-escalation study.
Peeva, Elena; Hodge, Martin R; Kieras, Elizabeth; Vazquez, Michael L; Goteti, Kosalaram; Tarabar, Sanela G; Alvey, Christine W; Banfield, Christopher.
Affiliation
  • Peeva E; Pfizer, Cambridge, MA, USA.
  • Hodge MR; Pfizer, Cambridge, MA, USA.
  • Kieras E; Pfizer, Cambridge, MA, USA.
  • Vazquez ML; Pfizer, Cambridge, MA, USA.
  • Goteti K; Pfizer, Cambridge, MA, USA.
  • Tarabar SG; Pfizer, New Haven, CT, USA.
  • Alvey CW; Pfizer, Groton, CT, USA.
  • Banfield C; Pfizer, Cambridge, MA, USA.
Br J Clin Pharmacol ; 84(8): 1776-1788, 2018 08.
Article in En | MEDLINE | ID: mdl-29672897
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Protein Kinase Inhibitors / Janus Kinase 1 Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Br J Clin Pharmacol Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Pyrimidines / Sulfonamides / Protein Kinase Inhibitors / Janus Kinase 1 Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Br J Clin Pharmacol Year: 2018 Document type: Article